Falcon Point Capital, Llc Buys Cardiovascular Systems Inc, Merit Medical Systems Inc, ICF International Inc, Sells Supernus Pharmaceuticals Inc, Omnicell Inc, Hostess Brands Inc

San Francisco, CA, based Investment company Falcon Point Capital, Llc buys Cardiovascular Systems Inc, Merit Medical Systems Inc, ICF International Inc, Upland Software Inc, Ligand Pharmaceuticals Inc, WageWorks Inc, Limelight Networks Inc, Systemax Inc, IntriCon Corp, R1 RCM Inc, Harvard Bioscience Inc, CoStar Group Inc, Wheaton Precious Metals Corp, Mastercard Inc, American Homes 4 Rent, Wintrust Financial Corp, Microsoft Corp, QuinStreet Inc, PetIQ Inc, The Hackett Group Inc, Caesars Entertainment Corp, sells Supernus Pharmaceuticals Inc, Omnicell Inc, Hostess Brands Inc, Myriad Genetics Inc, Granite Construction Inc, BioTelemetry Inc, Medical Properties Trust Inc, NeoGenomics Inc, Conn's Inc, Carbonite Inc, Tutor Perini Corp, Antares Pharma Inc, Diamond Hill Investment Group Inc, Electro Scientific Industries Inc, Vishay Precision Group Inc, Quantenna Communications Inc, Allied Motion Technologies Inc, Social Capital Hedosophia Holdings Corp, ViewRay Inc, Goldcorp Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Falcon Point Capital, Llc. As of 2019Q1, Falcon Point Capital, Llc owns 93 stocks with a total value of $180 million. These are the details of the buys and sells.

For the details of FALCON POINT CAPITAL, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/falcon+point+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of FALCON POINT CAPITAL, LLC
  1. FireEye Inc (FEYE) - 414,285 shares, 3.86% of the total portfolio. Shares reduced by 5.23%
  2. Eldorado Resorts Inc (ERI) - 133,405 shares, 3.46% of the total portfolio. Shares reduced by 5.15%
  3. Fortress Transportation and Infrastructure Investo (FTAI) - 346,315 shares, 3.29% of the total portfolio. Shares reduced by 2.94%
  4. Proofpoint Inc (PFPT) - 48,561 shares, 3.28% of the total portfolio. Shares reduced by 8.85%
  5. Cardiovascular Systems Inc (CSII) - 143,828 shares, 3.09% of the total portfolio. Shares added by 650.98%
New Purchase: Merit Medical Systems Inc (MMSI)

Falcon Point Capital, Llc initiated holding in Merit Medical Systems Inc. The purchase prices were between $50.86 and $61.83, with an estimated average price of $56.71. The stock is now traded at around $57.20. The impact to a portfolio due to this purchase was 2.1%. The holding were 61,087 shares as of .

New Purchase: Upland Software Inc (UPLD)

Falcon Point Capital, Llc initiated holding in Upland Software Inc. The purchase prices were between $26.6 and $43.55, with an estimated average price of $33.84. The stock is now traded at around $44.01. The impact to a portfolio due to this purchase was 0.5%. The holding were 21,268 shares as of .

New Purchase: Systemax Inc (SYX)

Falcon Point Capital, Llc initiated holding in Systemax Inc. The purchase prices were between $20.23 and $25.19, with an estimated average price of $22.89. The stock is now traded at around $23.35. The impact to a portfolio due to this purchase was 0.33%. The holding were 25,964 shares as of .

New Purchase: IntriCon Corp (IIN)

Falcon Point Capital, Llc initiated holding in IntriCon Corp. The purchase prices were between $21.54 and $29.43, with an estimated average price of $25.48. The stock is now traded at around $25.37. The impact to a portfolio due to this purchase was 0.3%. The holding were 21,799 shares as of .

New Purchase: Harvard Bioscience Inc (HBIO)

Falcon Point Capital, Llc initiated holding in Harvard Bioscience Inc. The purchase prices were between $2.77 and $4.38, with an estimated average price of $3.62. The stock is now traded at around $2.88. The impact to a portfolio due to this purchase was 0.25%. The holding were 104,350 shares as of .

New Purchase: CoStar Group Inc (CSGP)

Falcon Point Capital, Llc initiated holding in CoStar Group Inc. The purchase prices were between $327.28 and $476.88, with an estimated average price of $411.41. The stock is now traded at around $495.31. The impact to a portfolio due to this purchase was 0.16%. The holding were 636 shares as of .

Added: Cardiovascular Systems Inc (CSII)

Falcon Point Capital, Llc added to a holding in Cardiovascular Systems Inc by 650.98%. The purchase prices were between $26.74 and $41.32, with an estimated average price of $33.73. The stock is now traded at around $40.80. The impact to a portfolio due to this purchase was 2.68%. The holding were 143,828 shares as of .

Added: ICF International Inc (ICFI)

Falcon Point Capital, Llc added to a holding in ICF International Inc by 150.80%. The purchase prices were between $61.97 and $77.75, with an estimated average price of $70.42. The stock is now traded at around $76.39. The impact to a portfolio due to this purchase was 1.26%. The holding were 49,689 shares as of .

Added: Ligand Pharmaceuticals Inc (LGND)

Falcon Point Capital, Llc added to a holding in Ligand Pharmaceuticals Inc by 27.90%. The purchase prices were between $105.93 and $142.47, with an estimated average price of $121.61. The stock is now traded at around $120.62. The impact to a portfolio due to this purchase was 0.46%. The holding were 30,505 shares as of .

Added: WageWorks Inc (WAGE)

Falcon Point Capital, Llc added to a holding in WageWorks Inc by 21.57%. The purchase prices were between $26.38 and $39.83, with an estimated average price of $32.57. The stock is now traded at around $49.42. The impact to a portfolio due to this purchase was 0.45%. The holding were 121,784 shares as of .

Added: Limelight Networks Inc (LLNW)

Falcon Point Capital, Llc added to a holding in Limelight Networks Inc by 36.00%. The purchase prices were between $2.34 and $3.23, with an estimated average price of $2.89. The stock is now traded at around $3.02. The impact to a portfolio due to this purchase was 0.41%. The holding were 868,970 shares as of .

Added: R1 RCM Inc (RCM)

Falcon Point Capital, Llc added to a holding in R1 RCM Inc by 396.70%. The purchase prices were between $7.52 and $10.15, with an estimated average price of $9.03. The stock is now traded at around $10.73. The impact to a portfolio due to this purchase was 0.3%. The holding were 69,667 shares as of .

Sold Out: Supernus Pharmaceuticals Inc (SUPN)

Falcon Point Capital, Llc sold out a holding in Supernus Pharmaceuticals Inc. The sale prices were between $32.77 and $41.99, with an estimated average price of $37.19.

Sold Out: Hostess Brands Inc (TWNK)

Falcon Point Capital, Llc sold out a holding in Hostess Brands Inc. The sale prices were between $10.94 and $12.5, with an estimated average price of $11.67.

Sold Out: Myriad Genetics Inc (MYGN)

Falcon Point Capital, Llc sold out a holding in Myriad Genetics Inc. The sale prices were between $26.93 and $34.7, with an estimated average price of $30.42.

Sold Out: Granite Construction Inc (GVA)

Falcon Point Capital, Llc sold out a holding in Granite Construction Inc. The sale prices were between $40.1 and $48.43, with an estimated average price of $44.49.

Sold Out: Carbonite Inc (CARB)

Falcon Point Capital, Llc sold out a holding in Carbonite Inc. The sale prices were between $21.87 and $29.45, with an estimated average price of $25.7.

Sold Out: Tutor Perini Corp (TPC)

Falcon Point Capital, Llc sold out a holding in Tutor Perini Corp. The sale prices were between $15.41 and $19.24, with an estimated average price of $17.5.



Here is the complete portfolio of FALCON POINT CAPITAL, LLC. Also check out:

1. FALCON POINT CAPITAL, LLC's Undervalued Stocks
2. FALCON POINT CAPITAL, LLC's Top Growth Companies, and
3. FALCON POINT CAPITAL, LLC's High Yield stocks
4. Stocks that FALCON POINT CAPITAL, LLC keeps buying